Patent details

EP3925950 Title: SYNTHESIS OF OMECAMTIV MECARBIL

Basic Information

Publication number:
EP3925950
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP211742622
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SYNTHESIS OF OMECAMTIV MECARBIL
French Title of Invention:
SYNTHÈSE D'OMECAMTIV MECARBIL
German Title of Invention:
SYNTHESE VON OMECAMTIV MECARBIL
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
05/10/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
16/10/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
06/09/2023
Unitary Effect Registration Date:
16/10/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
29/06/2018
Grant date:
06/09/2023
EP Publication Date:
22/12/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2023
EP B1 Publication Date:
06/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/06/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/08/2023
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:
QUAN, Peter Bin
Address:
United States (US)

2

Name:
SHI, Xianqing
Address:
United States (US)

3

Name:
COSBIE, Andrew
Address:
United States (US)

4

Name:
CAILLE, Sebastien
Address:
United States (US)

5

Name:
GUAN, Lianxiu
Address:
United States (US)

6

Name:
QUASDORF, Kyle
Address:
United States (US)

7

Name:
NEERGUNDA, Archana
Address:
United States (US)

8

Name:
WU, Zufan
Address:
United States (US)

9

Name:
ROOSEN, Philipp
Address:
United States (US)

10

Name:
WANG, Fang
Address:
United States (US)

Priority

1

Priority Number:
201762527174 P
Priority Date:
30/06/2017
Priority Country:
United States (US)

2

Priority Number:
201862664363 P
Priority Date:
30/04/2018
Priority Country:
United States (US)

Classification

IPC classification:
C07D 213/75;

Publication

European Patent Bulletin

1

Issue number:
202336
Publication date:
06/09/2023
Description:
Grant (B1)

2

Issue number:
202345
Publication date:
08/11/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202346
Publication date:
15/11/2023
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages